Organ-specific response to nivolumab in patients with non-small cell lung cancer (NSCLC)

被引：0
|
作者：
Sabine Schmid
Stefan Diem
Qiyu Li
Mirjam Krapf
Lukas Flatz
Sebastian Leschka
Lotus Desbiolles
Dirk Klingbiel
Wolfram Jochum
Martin Früh
机构：
[1] Cantonal Hospital St. Gallen,Department of Oncology and Haematology
[2] Swiss Group for Clinical Cancer Research,SAKK
[3] University of Bern,Department of Immunbiology
[4] Cantonal Hospital St. Gallen,Department of Radiology
[5] Cantonal Hospital St. Gallen,Institute of Pathology
[6] Cantonal Hospital St. Gallen,Department of Oncology/Haematology
[7] Spital Grabs,undefined
来源：
Cancer Immunology, Immunotherapy | 2018年 / 67卷
关键词：
NSCLC; Patterns of response; Organ-specific response; Checkpoint inhibitors;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1825 / 1832
页数：7
相关论文
共 50 条
  • [1] Organ-specific response to nivolumab in patients with non-small cell lung cancer (NSCLC)
    Schmid, Sabine
    Diem, Stefan
    Li, Qiyu
    Krapf, Mirjam
    Flatz, Lukas
    Leschka, Sebastian
    Desbiolles, Lotus
    Klingbiel, Dirk
    Jochum, Wolfram
    Fruh, Martin
    [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 2018, 67 (12) : 1825 - 1832
  • [2] Patterns of Response to Nivolumab in Patients with Non-Small Cell Lung Cancer (NSCLC)
    Schmid, S.
    Diem, S.
    Krapf, M.
    Li, Q.
    Flatz, L.
    Leschka, S.
    Desbiolles, L.
    Klingbiel, D.
    Jochum, W.
    Fruh, M.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2419 - S2420
  • [3] Outcomes of Nivolumab in Elderly Patients (pts) with Non-Small Cell Lung Cancer (NSCLC)
    Bagley, Stephen
    Kothari, Shawn
    Aggarwal, Charu
    Bauml, Joshua
    Alley, Evan
    Evans, Tracey
    Kosteva, John
    Ciunci, Christine
    Thompson, Jeffrey
    Stonehouse-Lee, Susan
    Sherry, Victoria
    Gilbert, Elizabeth
    Eaby-Sandy, Beth
    Mutale, Faith
    Dilullo, Gloria
    Cohen, Roger
    Vachani, Anil
    Langer, Corey
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1289 - S1289
  • [4] Nivolumab in Non-Small Cell Lung Cancer (NSCLC): Facing the Reality
    Merimsky, O.
    Shamai, S.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2425 - S2425
  • [5] Phase II study of nivolumab in patients with advanced non-small cell lung cancer (NSCLC) in Korea
    Cho, E. K.
    Kang, J. H.
    Han, J-Y.
    Lee, J. S.
    Kim, D-W.
    Kim, S-W.
    Min, Y. J.
    Lee, K. H.
    Kim, J-H.
    Park, K.
    [J]. ANNALS OF ONCOLOGY, 2017, 28
  • [6] Single-center experience with nivolumab in pretreated patients with non-small cell lung cancer (NSCLC).
    Rapoport, Bernardo Leon
    Smit, Teresa
    van Eeden, Ronwyn
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (07)
  • [7] Specific organ metastases and survival of advanced non-small cell lung cancer (NSCLC) patients with EGFR mutation.
    Shi, Tiantian
    Wang, Long
    Fan, Zhisong
    Feng, Li
    Han, Jing
    Su, Yu
    Zhou, Xinliang
    Zuo, Jing
    Liu, Fengling
    Jiang, Da
    Xu, Xiaoli
    Wang, Yudong
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [8] Nivolumab in Non-Small Cell Lung Cancer (NSCLC): The Real-Life Data
    Dudnik, Elizabeth
    Moskovitz, Mor
    Daher, Sameh
    Shamai, Sivan
    Hanovich, Ekaterina
    Shechtman, Yelena
    Abu-Amna, Mahmoud
    Zer, Alona
    Wollner, Mira
    Bar, Jair
    Merimsky, Ofer
    Cyjon, Arnold
    Shochat, Tzippy
    Peled, Nir
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S417 - S418
  • [9] Nivolumab in Non-Small Cell Lung Cancer (NSCLC): A Real-Life Study
    Reis, D.
    Mendes, A.
    China, N.
    Dias, M.
    Coutinho, D.
    Silva, E.
    Campainha, S.
    Costa, T.
    Conde, S.
    Barroso, A.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S975 - S976
  • [10] Immune suppressive microenvironment in liver metastases contributes to organ-specific response of immunotherapy in advanced non-small cell lung cancer
    Deng, Jia-Yi
    Gou, Qing
    Yang, Lingling
    Chen, Zhi-Hong
    Yang, Ming-Yi
    Yang, Xiao-Rong
    Yan, Hong-Hong
    Wei, Xue-Wu
    Liu, Jia-Qi
    Su, Jian
    Zhong, Wen-Zhao
    Xu, Chong-Rui
    Wu, Yi-Long
    Zhou, Qing
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2023, 11 (07)
12345